日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)

一项评估索非喹啉或贝达喹啉联合普瑞托马尼和利奈唑胺治疗新诊断的、药物敏感的、涂片阳性肺结核成年患者的安全性和有效性的 2 期、部分盲法、随机试验方案 (NC-009)

Olugbosi, M; Beumont, M; Lombard, L; Nedelman, J; Timm, J; Black, T; Bruning-Barry, R; Hickman, D; Lombardi, A; Betteridge, M; Egizi, E; Marcopulos, L; Henderson, J; Seidel, S; Foraida, S; Benhayoun, M; Sun, E

panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbe

panTB-HM:一项针对宿主和微生物的泛结核病治疗方案的多臂临床试验

Mudzengi, D; Mashatole, S; Xiang, Q; Adrion, C; Glover, N; Ngwanto, T; Mdluli, J; Boniface, S; Rassool, M; Matome, B; Paramo, L; Svensson, E; Fasanmi, A; Angelo, S; Moyo, M; Marx, C; Khosa, C; Mokaba, L; Mofokeng, N; Lalashowi, J; Nacy, C; Charalambous, S; Fumane, E; Maphossa, V; Beattie, T; Brumskine, W; Venter, C; Mapamba, D; Heinrich, N; Rajaram, S; Kooverjee, S; Botha, L; Nell, M; Easton, A; Foraida, S; Warren, Robin Mark; Sabi, Issa; Ntinginya, N; Wallis, R S

A mixed-method study to inform the development of long-acting injectable TB treatments

一项采用混合方法的研究,旨在为长效注射型结核病治疗药物的研发提供信息。

Bayot, A J F; Gler, M T; Tolley, E E; Lorenzetti, L; Namey, E; Dinh, N; Martinez, A; Audibert, C; Foraida, S; Osborn, J; Holtzman, D; Vinnard, C; Talbot, E A; Wells, C

Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: an individual patient data meta-analysis

利奈唑胺治疗多重耐药和利福平耐药结核病的最佳剂量和疗程:一项个体患者数据荟萃分析

Kwak, Nakwon; Kim, Joong-Yub; Han, Areum; Berry, Catherine; Beumont, Maria; Tweed, Conor; Crook, Angela; Dheda, Keertan; Fabiane, Stella; Fadeyi, Muse O; Foraida, Salah; Gils, Tinne; Hoang, Thi Thanh Thuy; Jham, Menal A; Murphy, Richard A; Nguyen, Binh Hoa; Nguyen, Thi Mai Phuong; Nyang'wa, Bern Thomas; Oelofse, Suzette; Hahn, Seokyung; Yim, Jae-Joon

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

ACTG A5409 (RAD-TB):一项针对肺结核治疗新方案的 II 期随机、适应性、剂量范围、开放标签试验的研究方案

Harrison, Linda J; Velásquez, Gustavo E; Kempker, Russell R; Imperial, Marjorie Z; Nuermberger, Eric; Dorman, Susan E; Ignatius, Elisa; Granche, Janeway; Phillips, Patrick P J; Furin, Jennifer; Yang, Eunsol; Foley, Colleen; Chiambah, Shawn; Rogers, Rochelle; Van Grack, Austin; Roa, Jhoanna; Shenje, Justin; Nerette, Sandy; Kanyama, Cecilia; Kyeyune, Rachel Bakyayita; Mendoza-Ticona, Alberto; Murtaugh, William; Foraida, Salah; Goth, Melanie; Vernon, Andrew; Dooley, Kelly E; Savic, Radojka M

Treatment success rate and time to culture conversion under a prospective BPaL cohort study

前瞻性 BPaL 队列研究的治疗成功率和培养转阴时间

Burhan, E; Sugiharto, J; Soemarno, M; Juan, A; Runtu, Y; Yuvensia, A; Ramadhani, R; Sabono, J; Lailiyah, A; Fenni, F; Farikha, M; Pakasi, T; Pambudi, I; Mbenga, M; Koppelaar, I; Mirtskhulava, V; Wares, F; Jerene, D; Jung, J K; Lee, J S; Foraida, S; Juneja, S; Diachenko, M; Gebhard, A

The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis

利奈唑胺在包含贝达喹啉、普瑞托马尼和利奈唑胺的新型短程方案中治疗利福平耐药结核病的安全性和耐受性:一项个体患者数据荟萃分析

Hasan, Tasnim; Medcalf, Ellie; Nyang'wa, Bern-Thomas; Egizi, Erica; Berry, Catherine; Dodd, Matthew; Foraida, Salah; Gegia, Medea; Li, Mengchun; Mirzayev, Fuad; Morgan, Hannah; Motta, Ilaria; Nguyen, Linh; Schumacher, Samuel; Schlub, Tim; Fox, Greg

Integrated In Vivo and In Vitro Evaluation of a Powder-to-Hydrogel, Film-Forming Polymer Complex Base with Tissue-Protective and Microbiome-Supportive Properties

对具有组织保护和微生物组支持特性的粉末至水凝胶、成膜聚合物复合基质进行体内和体外综合评估

Daniel Banov, Guiyun Song, Zahraa Foraida, Oksana Tkachova, Oleksandr Zdoryk, Maria Carvalho

Introducing BPaL: Experiences from countries supported under the LIFT-TB project

BPaL简介:LIFT-TB项目支持国家的经验

Wares, D F; Mbenga, M; Mirtskhulava, V; Quelapio, M; Slyzkyi, A; Koppelaar, I; Cho, S N; Go, U; Lee, J S; Jung, J-K; Everitt, D; Foraida, S; Diachenko, M; Juneja, S; Burhan, E; Totkogonova, A; Myint, Z; Flores, I; Lytvynenko, N A; Parpieva, N; Nhung, N V; Gebhard, A

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB

全口服耐药结核病(DR-TB)治疗方案的快速分诊检测:一项评估Xpert MTB/XDR检测在DR-TB快速分诊和治疗中的有效性、可行性、可接受性和成本效益的IV期研究

Naidoo, Kogieleum; Naidoo, Anushka; Abimiku, Alash'le G; Tiemersma, Everdina W; Gebhard, Agnes; Hermans, Sabine M; Sloan, Derek J; Ruhwald, Morten; Georghiou, Sophia B; Okpokoro, Evaezi; Agbaje, Aderonke; Yae, Kalkidan; Tollera, Getachew; Moga, Shewki; Feyt, Hannelise; Kachoka, Takondwa; Letsoalo, Marothi P; Cabibbe, Andrea M; Perumal, Rubeshan; Shunmugam, Letitia; Cirillo, Daniela M; Foraida, Salah; Sabiiti, Wilber; Ntinginya, Nyanda Elias; Mtafya, Bariki; Bedru, Ahmed; Gillespie, Stephen H